Navigation Links
ExcitePCR to Hold Press Conference in Washington, D.C. on September 18

ExcitePCR™ today announced that it will hold a Press Conference at 10 a.m. on Monday, September 18 at the National Press Club in Washington, D.C.

During its Press Conference, ExcitePCR will

  •      Summarize its multiyear history in designing, developing and producing automated biohazard detection solutions for U.S. governmental agencies and military organizations,
  •     Showcase its forthcoming FireflyDX™ portable, realtime pathogen detection systems, and
  •     Release an ExcitePCR Executive Summary of a report produced for it by Lawrence Livermore National Laboratory.

An ExcitePCR Press Conference on Monday, September 18, 2017, from 10-11 a.m. (ET) will disclose details from a Lawrence Livermore National Laboratory Report prepared for the company that states that ExcitePCR’s FireflyDX automated pathogen detection technologies have no known direct competition. {NOTE: ExcitePCR will release its own Executive Summary of the LLNL Report during the Press Conference.}

During the press conference, ExcitePCR will also provide additional details about its lightweight, bookbag-sized FireflyDX-Portable™, a realtime pathogen detection system designed to enable first responders, medical professionals and food safety workers to accurately obtain on-site results anywhere in the world in less than 30 minutes, including sample preparation time.

The ExcitePCR Press Conference will be held at the National Press Club in Washington, D.C. at 529 14th Street NW, Washington, D.C.

The ExcitePCR Press Conference will be held from 10-11 a.m. (ET) on Monday, September 18, 2017.

Representing ExcitePCR at the Press Conference will be

  •     Lyle Probst, President, CEO, and Founder;
  •     Kimothy Smith, Ph.D., Chief Science Officer; and
  •     David Politis, Chief Marketing & Sales Officer.

Journalists & Analysts Who Should Attend:
Journalists and Analysts interested in and/or who cover/report on infectious diseases, pandemics, epidemics, biohazards, pathogenic threats, First Responders, Homeland Security, the military, and/or Polymerase Chain Reaction (PCR), as well as those who follow or have reported on such firms as Theranos, bioMerieux, Thermo Fisher Scientific, are those most likely to appreciate the information that will be shared during ExcitePCR’s September 18th Press Conference.

Including its predecessor companies, ExcitePCR has received over $35 million since 2004 from the U.S. Department of Homeland Security (DHS) and other U.S. governmental entities to design, develop and produce rapid pathogen detection solutions. This foundational work has allowed ExcitePCR to produce significant breakthroughs in the world of PCR-based solutions for rapidly and accurately identifying the presence of countless biological threats anywhere in the world, including the typically time-consuming act of sample preparation, all within 30 minutes or less. ExcitePCR has now begun work to commercialize its FireflyDX technologies.

Additional Information:    
Following the Press Conference on September 18, ExcitePCR’s CEO, Lyle Probst, will participate in a prestigious, three-person Panel Discussion that afternoon about current and future advancements in pathogen detection systems hosted by the National Academies of Sciences, Engineering, and Medicine (NAS). This Panel Discussion is part of a two-day, BioWatch Workshop on “Strategies for Effective Biological Detection Systems” hosted by the NAS. Interested parties can learn more about this Panel Discussion here.

About ExcitePCR
ExcitePCR Corporation is developing portable pathogen detection systems based upon superior sample preparation and realtime PCR (Polymerase Chain Reaction) methodologies. Its FireflyDX technologies will deliver rapid automated Point-of-Care/Point-of-Need (POC/PON) sample preparation and highly accurate biohazard identification in a fraction of the time currently possible using existing PCR-based solutions.

Disclaimer: This document may contain research results that are experimental in nature, and neither the United States Government, any agency thereof, Lawrence Livermore National Security, LLC, nor any of its employees makes any warranty, express or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. Reference to any specific commercial product, process, or service by trade name, trademark, manufacturer, or otherwise does not constitute or imply an endorsement or recommendation by the U.S. Government or Lawrence Livermore National Security, LLC. The views and opinions of authors expressed herein do not necessarily reflect those of the U.S. Government or Lawrence Livermore National Security, LLC and will not be used for advertising or product endorsement purposes.

ExcitePCR, FireflyDX and FireflyDX-Portable are each trademarks of ExcitePCR Corporation. All other trademarks are the property of their respective owners.

# # #

CONTACT: David Politis, dpolitis(at)excitepcr(dot)com, C: 801-556-8184

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related biology technology :

1. ExcitePCR’s CEO, Lyle Probst, Invited to Join Prestigious BioWatch Panel During Two-Day Workshop Hosted by the National Academies of Science, Engineering and Medicine
2. ExcitePCR Announces its FireflyDX-Portable: A Lightweight, Bookbag-sized Realtime Pathogen Detection System, with Commercial Availability Slated for Summer 2018
3. ExcitePCR Releases its Company Facts Sheet
4. Thirty-Year Marketing Veteran, David L. Politis, Joins ExcitePCR as its Chief Marketing & Sales Officer
5. Scientists Discover Existing Diabetes Drug Reduces Sight-threatening Rise in Brain Pressure
6. Cynvenio Announces New LiquidBiopsy® Test for PD-L2 Expression
7. Cynvenio Launches Newest LiquidBiopsy HER2 Expression Test
8. How Do You Like Them Apples? Dynamic Cellular Disruption Proves Solution to a ‘Pressing’ Problem in the Natural Sugar Concentrates Market
9. HumanZyme® Announces Human Cell-Expressed Interferon beta for Immunology and Immunotherapy Research Applications
10. Cynvenio Announces New LiquidBiopsy Test for PD-L1 Expression in Lung Cancer
11. Xulon Press Announces New Book Addressing the Chemical Composition of a Brain Chip
Post Your Comments:
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
(Date:10/10/2017)... International research firm Parks Associates announced today that Tom ... 2017 Annual Meeting , October 11 in Scottsdale, Arizona ... and how smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and ...
(Date:10/9/2017)... , ... October 09, 2017 , ... The award-winning American ... broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on RFD-TV. , ... faced with the challenge of how to continue to feed a growing nation. At ...
(Date:10/7/2017)... , ... October 06, 2017 ... ... in Hi-C-based genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring ... kit and accompanying cloud-based bioinformatics software to perform Hi-C metagenome deconvolution using ...
Breaking Biology Technology:
(Date:4/24/2017)... April 24, 2017 Janice Kephart ... with  Identity Strategy Partners, LLP (IdSP) , today ... without President Trump,s March 6, 2017 Executive ... , refugee vetting can be instilled with greater confidence, ... now, all refugee applications are suspended by until ...
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
(Date:4/11/2017)... BROOKLYN, N.Y. , April 11, 2017 /PRNewswire-USNewswire/ ... identical fingerprints, but researchers at the New York ... University College of Engineering have found that partial ... fingerprint-based security systems used in mobile phones and ... previously thought. The vulnerability lies in ...
Breaking Biology News(10 mins):